Extensive myocardial infiltration by hemopoietic precursors in a patient with myelodysplastic syndrome
- PMID: 16953890
- PMCID: PMC1569821
- DOI: 10.1186/1471-2326-6-4
Extensive myocardial infiltration by hemopoietic precursors in a patient with myelodysplastic syndrome
Abstract
Background: Although myocardial infiltration with leukemic blasts is a known finding in patients with acute leukemia, this phenomenon in myelodysplasia is not reported in the literature. Cardiac symptoms in patients with myelodysplasia are often due to anemia and may be due to iron overload and side effects of therapy.
Case presentation: Herein we report the first case of neoplastic infiltration of the heart with associated myocardial necrosis in a patient with myelodysplasia. It was associated with unicellular and multifocal geographic areas of necrosis in the left ventricle and the interventricular septum. It is likely that cardiac compromise in our patient was due to a combination of restrictive cardiomyopathy due to leukemic infiltration, concomitant anemia, cardiac dilatation, conduction blocks and myocardial necrosis. Myocardial necrosis was most likely due to a combination of ischemic damage secondary to anemia and prolonged hypotension and extensive leukemic infiltration. Markedly rapid decrease in ejection fraction from 66% to 33% also suggests the role of ischemia, since leukemic infiltration is not expected to cause this degree of systolic dysfunction over a 24-hour period. The diagnosis was not suspected during life due to concomitant signs and symptoms of anemia, pulmonary infections, and pericardial and pleural effusions. The patient succumbed to cardiac failure.
Conclusion: Hemopoietic cell infiltration was not considered in the differential diagnosis and contributed to this patient's morbidity and mortality. This case highlights the clinical importance of considering myocardial infiltration in patients with myelodysplasia and cardiac symptoms.
Figures









Similar articles
-
Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.Dan Med Bull. 2001 Nov;48(4):199-210. Dan Med Bull. 2001. PMID: 11767125 Review.
-
[Pathological study of unexpected sudden death clustered in family or village in Yunnan province: report of 29 cases of autopsy].Zhonghua Yi Xue Za Zhi. 2007 Aug 21;87(31):2209-14. Zhonghua Yi Xue Za Zhi. 2007. PMID: 18001532 Chinese.
-
Leukemic infiltration presenting as myocardial hypertrophy after complete remission of acute myeloid leukemia.Echocardiography. 2017 Jan;34(1):136-138. doi: 10.1111/echo.13404. Epub 2016 Oct 25. Echocardiography. 2017. PMID: 27779355
-
Necrotizing myocardial vasculitis in Churg-Strauss syndrome: clinicohistologic evaluation of steroids and immunosuppressive therapy.Chest. 1998 Nov;114(5):1484-9. doi: 10.1378/chest.114.5.1484. Chest. 1998. PMID: 9824037
-
Pleural effusions in acute and chronic leukemia and myelodysplastic syndrome.Curr Opin Pulm Med. 2014 Jul;20(4):340-6. doi: 10.1097/MCP.0000000000000060. Curr Opin Pulm Med. 2014. PMID: 24811835 Review.
Cited by
-
Bradycardia following retinoic acid differentiation syndrome in a patient with acute promyelocytic leukaemia.BMJ Case Rep. 2012 Jul 9;2012:bcr0220125848. doi: 10.1136/bcr.02.2012.5848. BMJ Case Rep. 2012. PMID: 22778455 Free PMC article.
-
Cardiac Myeloid Sarcoma: Review of Literature.J Clin Diagn Res. 2017 Mar;11(3):XE01-XE04. doi: 10.7860/JCDR/2017/23241.9499. Epub 2017 Mar 1. J Clin Diagn Res. 2017. PMID: 28511492 Free PMC article. Review.
-
Cardiac ALL: Most Unusual Occurrence of Lenalidomide-associated Acute Lymphoblastic Leukemia with Subsequent Cardiac Involvement.Cureus. 2019 Oct 28;11(10):e6009. doi: 10.7759/cureus.6009. Cureus. 2019. PMID: 31815073 Free PMC article.
-
Therapy-related myelodysplastic syndrome presenting as fulminant heart failure secondary to myeloid sarcoma.J Hematop. 2010 May 5;3(1):41-6. doi: 10.1007/s12308-010-0058-4. J Hematop. 2010. PMID: 21544187 Free PMC article.
-
Utility of magnetic resonance imaging in the evaluation of left ventricular thickening.Insights Imaging. 2017 Apr;8(2):279-293. doi: 10.1007/s13244-017-0549-2. Epub 2017 Mar 9. Insights Imaging. 2017. PMID: 28281159 Free PMC article. Review.
References
-
- Brunning RD, Bennett JM, Flandrin G, Matutes E, Head D, Vardiman JW, Harris NL. Myelodysplastic syndromes. In: Jaffe ES, Harris NL, Stein S, Vardiman JW, editor. Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. Vol. 3. Lyon, France , IARC Press; 2001. pp. 61–74. (World Health Organization Classification of Tumors). P Kleihaus.
-
- Bennett JM, Komrokji R, Kouides PA. The myelodysplastic syndromes. In: Abeloff MD, Armitage JO, Niederhuber JE, editor. Clinical Oncology. 3rd. New York, NY , Churchill Livingstone; 2004. pp. 2849–2881.
-
- Greenberg PL, Baer MR, Bennett JM, Bloomfield CD, De Castro CM, Deeg HJ, Devetten MP, Emanuel PD, Erba HP, Estey E, Foran J, Gore SD, Millenson M, Navarro WH, Nimer SD, O'Donnell MR, Saba HI, Spiers K, Stone RM, Tallman MS. Myelodysplastic syndromes clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2006;4:58–77. - PubMed
-
- Steensma DP, Bennett JM. The myelodysplastic syndromes: diagnosis and treatment. Mayo Clin Proc. 2006;81:104–130. - PubMed
-
- Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89:2079–2088. - PubMed
LinkOut - more resources
Full Text Sources